Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
Catherine Wilson(Discovery Centre), Jeff Settleman(Discovery Centre)
Cited by 142
Related Papers
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
|Cancer Research|2014|308
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
|Cancer Research|2014|145